StockComparison Logo
vs

NEM vs GSK

Comparison between Newmont Corp (NEM, Company) and GSK Plc (GSK, Company).

NEM is from the Basic Materials sector, while GSK is from the Healthcare sector.

5-Year PerformanceNEM has outperformed GSK, delivering a return of +12.1% compared to +4.9%

NEM vs GSK - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
NEM
$103B
Winner
GSK
$105B
Max Drawdown
NEM
78.44%
Winner
GSK
64.03%
Sharpe Ratio
NEM
1.16
Winner
GSK
1.37
5Y Beta
NEM
0.81
Winner
GSK
0.23
Industry
NEM
Gold
GSK
Drug Manufacturers - General
P/E Ratio
Winner
NEM
11.59
GSK
12.10
Forward P/E
Winner
NEM
9.46
GSK
21.69
PEG Ratio
Winner
NEM
0.03
GSK
0.10
Dividend Yield
NEM
1.14%
Winner
GSK
3.59%
5Y Dividends CAGR
NEM
-2.62%
Winner
GSK
1.34%
5Y EPS CAGR
Winner
NEM
82.55%
GSK
4.65%
Debt to Equity
Winner
NEM
14.54%
GSK
106.74%
Free Cash Flow Yield
Winner
NEM
11.70%
GSK
8.03%
P/S Ratio
NEM
3.88
Winner
GSK
3.22
P/B Ratio
Winner
NEM
2.91
GSK
4.37

NEM vs GSK - Historical Returns

Returns include dividend reinvestment.

1M
NEM
-9.15%
Winner
GSK
+0.08%
3M
NEM
-15.17%
Winner
GSK
-8.79%
6M
NEM
-21.86%
Winner
GSK
+7.35%
1Y
Winner
NEM
+56.17%
GSK
+45.38%
5Y(CAGR)
Winner
NEM
+12.10%
GSK
+4.87%
10Y(CAGR)
Winner
NEM
+11.30%
GSK
+4.02%
Max(CAGR)
Winner
NEM
+7.48%
GSK
+3.05%

NEM vs GSK - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearNEMGSK
2026-8.20%+3.98%
2025+164.61%+50.62%
2024-6.78%-6.27%
2023-13.16%+9.25%
2022-19.45%-32.73%
2021+1.88%+23.62%
2020+41.03%-17.52%
2019+31.21%+30.36%
2018-7.71%+9.29%
2017+9.11%-3.80%
2016+85.47%+1.52%
2015-6.51%+0.48%
2014-20.37%-14.73%
2013-49.02%+26.97%
2012-23.06%-0.75%
2011-0.13%+22.51%
2010+27.88%-3.72%
2009+18.35%+20.27%
2008-21.54%-21.93%
2007+11.49%-2.77%
2006-20.35%+6.93%
2005+27.26%+9.96%
2004-8.08%+5.08%
2003+64.46%+25.04%
2002+52.76%-22.83%
2001+7.18%-9.58%
2000-28.66%+5.67%
1999+18.91%-5.78%

NEM vs GSK Drawdown Comparison

The maximum drawdown for NEM was -76.55%, occurring on Sep 23, 2015. Recovery took 2127 trading sessions.

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The current NEM drawdown is -29.58%. The current GSK drawdown is -15.65%.

RankNEMGSK
#1-76.55%
Nov 7, 2011 - Apr 23, 2020
-50.11%
Apr 13, 2022 - Jan 6, 2026
#2-64.40%
Feb 1, 2006 - Jun 17, 2010
-49.64%
Apr 20, 2007 - Apr 18, 2012
#3-62.43%
Apr 18, 2022 - Sep 10, 2025
-45.23%
Apr 25, 2000 - Nov 11, 2005
#4-53.02%
May 4, 2000 - Mar 27, 2002
-32.56%
Jan 17, 2020 - Dec 10, 2021
#5-32.09%
Jan 28, 2026 - Jul 20, 2026
-27.97%
Mar 4, 2014 - Sep 3, 2019
#6-30.53%
May 28, 2002 - Jun 5, 2003
-26.98%
Nov 5, 1999 - Apr 11, 2000
#7-29.09%
Dec 2, 2003 - Dec 7, 2005
-18.61%
Feb 18, 2026 - Jun 2, 2026
#8-27.15%
May 18, 2021 - Mar 4, 2022
-14.45%
Jan 18, 2022 - Apr 7, 2022
#9-22.19%
Nov 24, 1999 - Feb 22, 2000
-10.52%
May 16, 2006 - Feb 13, 2007
#10-22.00%
Sep 22, 2010 - Sep 2, 2011
-10.48%
Oct 4, 2012 - Mar 22, 2013
#11-21.92%
Aug 5, 2020 - May 14, 2021
-8.45%
May 28, 2013 - Nov 1, 2013
#12-19.99%
Oct 16, 2025 - Dec 11, 2025
-8.43%
Apr 11, 2000 - Apr 25, 2000
#13-18.99%
May 15, 2020 - Jul 27, 2020
-8.16%
Nov 11, 2005 - Mar 8, 2006
#14-14.85%
Feb 22, 2000 - May 2, 2000
-7.54%
Feb 14, 2007 - Apr 16, 2007
#15-12.33%
Sep 20, 2011 - Nov 7, 2011
-7.37%
Jan 21, 2014 - Feb 13, 2014

Correlation

Correlation between NEM and GSK is 0.63 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.63
-101

Dividend Comparison (1999 - 2026)

NEM vs GSK dividend yield comparison.

YearNEMGSK
20260.56%1.74%
20251.00%3.42%
20242.69%4.60%
20233.87%3.75%
20224.66%5.47%
20213.55%4.99%
20201.74%5.59%
20193.31%4.35%
20181.62%5.65%
20170.67%5.83%
20160.37%6.86%
20150.56%5.93%
20141.19%6.20%
20135.32%4.51%
20123.01%5.70%
20111.67%4.83%
20100.81%5.10%
20090.85%4.39%
20080.98%5.74%
20070.82%4.09%
20060.89%3.29%
20050.75%3.03%
20040.68%3.38%
20030.35%2.77%
20020.41%3.10%
20010.63%1.54%
20000.70%4.57%
19990.12%0.00%

Select Stocks to Compare